AMZN
Amazon.com, Inc.
AMZN has the edge over CPHC overall, supported by stronger valuation and stronger modeled upside.
CPHC
Canterbury Park Holding Corporation
CPHC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CPHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CPHC's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CPHC in the historical PE scenario, which offers more potential upside but is not a forecast.
CPHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.8x | $0.98 | -94% |
| Fair | 17x | $1.66 | -89% |
| Expensive | 60x | $5.98 | -62% |
| Current | 157x | $15.70 | — |
Historical ranges are pointers, not guarantees.
CPHC's PE is in its expensive range at 157x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CPHC Forward outlook
There aren't enough analyst estimates for CPHC to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CPHC on earnings, with more consistent year-over-year improvement.
CPHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.10 | +$0.37 |
| Q2 2026 | $0.02 | -33% |
| Q1 2026 | -$0.01 | -106% |
| Q4 2025 | -$0.10 | -124% |
| Q3 2025 | -$0.27 | -129% |
| Q2 2025 | $0.03 | -96% |
| Q1 2025 | $0.16 | -91% |
| Q4 2024 | $0.42 | -80% |
CPHC has returned to profit: it earned $0.10 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CPHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CPHC on profitability, with a higher operating margin.
CPHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.1M | +4.2% |
| Q2 2026 | $16.2M | +3.2% |
| Q1 2026 | $13.5M | +2.8% |
| Q4 2025 | $12.4M | +3.9% |
| Q3 2025 | $18.3M | -5% |
| Q2 2025 | $15.7M | -3.3% |
| Q1 2025 | $13.1M | -6.8% |
| Q4 2024 | $12M | -4.4% |
CPHC's revenue grew through 2023 and has held roughly level since: $19M last quarter, up 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | +3.2 points |
| Q2 2026 | 1.8% | -1 points |
| Q1 2026 | 7.8% | +2.9 points |
| Q4 2025 | 2.6% | +3.5 points |
| Q3 2025 | 5.7% | -13 points |
| Q2 2025 | 2.8% | -4.2 points |
| Q1 2025 | 4.9% | -7.6 points |
| Q4 2024 | -0.8% | -5.5 points |
CPHC's operating margin was 8.9% last quarter, up 3.2 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CPHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +$3.1M |
| Q2 2026 | $3.6M | +11% |
| Q1 2026 | $2.6M | +3.6% |
| Q4 2025 | -$611.3K | +$6.1M |
| Q3 2025 | -$395.3K | -$395.3K |
| Q2 2025 | $3.2M | +78% |
| Q1 2025 | $2.5M | +$3.1M |
| Q4 2024 | -$6.7M | -$5.7M |
CPHC has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CPHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CPHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +54.4K shares |
| 1 year | +2.1% | +107K shares |
| 3 years | +5.2% | +258K shares |
| 5 years | +8.8% | +422K shares |
| Available history | +13% | +601K shares |
CPHC has 5M diluted shares, up 2.1% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CPHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
CPHC has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CPHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 70.6 | Neutral |
CPHC's weekly RSI is 48 (neutral) and its Stochastic is 71 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CPHC on valuation relative to its sector.
CPHC PE vs Consumer Cyclical Sector
| Metric | CPHC | Sector median | Relative |
|---|---|---|---|
| PE | 157x | 18x | 771% above |
| PE % | 92 | 47 | 45 pts above |
CPHC is trading at 157x earnings, a 771% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CPHC on trend strength, trading above more of its moving averages.
CPHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.8 | 0.3% below |
| 20 week MA | $15.8 | 0.4% below |
| 50 week MA | $15.7 | 0.3% above |
| 100 week MA | $16.9 | 7% below |
| 200 week MA | $19.5 | 19% below |
CPHC's trend is mixed: it's above one of its five weekly moving averages, and 19% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CPHC on returns for 2026, with the stronger performance.
CPHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $12.4 | -0.5% |
| 2021 | $12.4 | $17.6 | +42% |
| 2022 | $17.6 | $28.8 | +64% |
| 2023 | $28.8 | $20.4 | -29% |
| 2024 | $20.4 | $21.9 | +7.2% |
| 2025 | $21.9 | $15.3 | -30% |
| 2026 YTD | $15.3 | $15.7 | +2.5% |
CPHC has finished lower in three of the last six years. It's up 2.5% so far in 2026.